CHARLES HOWE: Open Payments
NPI 1568493096 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 23 payments from 12 companies in 2025. Trend: 2023 $663 · 2024 $232 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $115 |
| Vanda Pharmaceuticals Inc. | 2 | $107 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $39 |
| EMD Serono, Inc. | 2 | $37 |
| ARGENX US, INC. | 2 | $36 |
| Globus Medical, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: PONVORY, BOTOX, QULIPTA, Symbravo, LUMRYZ, Senza, KESIMPTA, ULTOMIRIS.
Industry payments across IN — which companies pay providers there.
